Ubie And CMI Media Group Partner To Transform Direct-To-Consumer Advertising, Beginning With Women's Health And Hematology/Oncology
Author: Benzinga Newsdesk | May 13, 2025 09:44am
- There is a critical need for trustworthy, hyper-personalized information earlier in the diagnosis and treatment journey to empower patients to participate in their care
- The partnership will initially focus on endometriosis and hematology; high-need therapeutic areas where patients are actively seeking information
- Connecting tailored information with relevant, motivated audiences will reinvent the way DTC advertising interacts and engages with consumers
NEW YORK, May 13, 2025 /PRNewswire/ -- Ubie, an AI-driven and medically vetted healthcare prediction platform that guides patients to the care they need, and CMI Media Group, a WPP (NYSE:WPP), healthcare media agency, announced a partnership aiming to transform direct-to-consumer (DTC) advertising, beginning with women's health and hematology/oncology. The collaboration integrates Ubie's AI Symptom Checker with CMI's precision media expertise to address the pharmaceutical industry's challenges in reaching patients with personalized, engaging messaging at scale. This combination will help accelerate time to diagnosis and the identification of the best available treatment.
Posted In: WPP